By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich today announced a partnership to develop methods to measure potential biomarkers for atherosclerosis cardiovascular disease in plasma samples from the Framingham Heart Study.

The partnership brings together Sigma-Aldrich, Boston University, and the National Institutes of Health's National Heart, Lung, and Blood Institute.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.

Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.

Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.